Advertisement
The risk of osteonecrosis of the jaw is highest in association with intravenous bisphosphonate use

Osteonecrosis of Jaw Risk Highest for IV Bisphosphonate Use

0
High risk for zoledronate, denosumab mainly in prevention of skeletal-related events
Intravenous cyclosporine does not improve outcomes versus placebo in patients with anterior ST-segment elevation myocardial infarction who had been referred for primary percutaneous coronary intervention. The findings were published online Aug. 30 in the New England Journal of Medicine to coincide with the annual European Society of Cardiology Congress

Intravenous Cyclosporine Doesn’t Improve STEMI Outcomes

0
For patients undergoing PCI, cyclosporine doesn't prevent adverse left ventricular remodeling at 1 year
Use of dipeptidyl peptidase-4 inhibitors in type 2 diabetes is tied to severe joint pain in some patients

FDA Warns of Joint Pain Tied to DPP-4 Inhibitors

0
Agency advises users with such symptoms to contact their doctor
For patients taking dabigatran

Lower Risk of Dabigatran-Tied Bleeding With Gastroprotection

0
Concomitant use of gastroprotective agents linked to lower risk of gastrointestinal bleeding
Taking antibiotics might increase the risk of developing type 2 diabetes

Antibiotic Use Linked to Higher Type 2 Diabetes Risk

0
Researchers don't know if the drugs signal developing disease, or contribute to it
Older women with osteoporosis may benefit from a few years on growth hormone

Growth Hormone May Benefit Bone Health in Older Women

0
But researcher says high cost, need to get shots in clinics make it an unlikely osteoporosis treatment
Use of the label "pink eye" versus "eye infection" is associated with increased parent intent to use antibiotics despite parents being informed about antibiotics' ineffectiveness for treating symptoms

Parents More Likely to Use Abx for ‘Pink Eye’ vs ‘Eye Infection’

0
Use of label 'pink eye' linked to increased intent to use antibiotics despite their ineffectiveness
Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration

FDA Approves Repatha for Certain Patients With High Cholesterol

0
Approved for patients unable to get LDL cholesterol under control with current treatment options
Many elderly oncology patients use complementary and alternative medications

Many Elderly Oncology Patients Taking Alternative Medicines

0
Associated with polypharmacy, vision impairment, and urologic comorbidities
Azithromycin is routinely prescribed to hospitalized patients despite risk factors for corrected QT prolongation and administration of interacting medications

Azithromycin Routine in Hospital Despite Risk for QTc Prolongation

0
Providers not considering risk of QTc-prolonging meds accumulation, authors say